A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
Clinical trial NCT03289143 · TERMINATED
Trial details
- NCT number
- NCT03289143
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2021-01-15
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.